We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.75B
AUM Growth
+$282M
Cap. Flow
+$98.4M
Cap. Flow %
3.57%
Top 10 Hldgs %
25.32%
Holding
537
New
191
Increased
80
Reduced
82
Closed
170

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$44.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$42.1M
3
SPLK
Splunk Inc
SPLK
+$32.5M
4
MSFT icon
Microsoft
MSFT
+$29.8M
5
ABBV icon
AbbVie
ABBV
+$29.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$61.8M
2
TJX icon
TJX Companies
TJX
+$44.7M
3
UBER icon
Uber
UBER
+$43.5M
4
STZ icon
Constellation Brands
STZ
+$38M
5
PYPL icon
PayPal
PYPL
+$34.2M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 12.59%
3 Industrials 10.36%
4 Healthcare 6.17%
5 Communication Services 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITB icon
201
iShares US Home Construction ETF
ITB
$2.32B
$2.17M 0.08%
25,351
+12,183
+93% +$926K
AMLX icon
202
Amylyx Pharmaceuticals
AMLX
$2.19B
$2.14M 0.08%
99,340
+31,062
+45% +$839K
REPL icon
203
CALL
Replimune Group
REPL
$455M
$2.13M 0.08%
+91,900
New +$1.8M
MDY icon
204
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$2.12M 0.08%
+4,419
New +$2.01M
STKL
205
CALL
DELISTED
SunOpta
STKL
$2.11M 0.08%
314,800
-36,000
-10% -$271K
PCRX icon
206
Pacira BioSciences
PCRX
$1.04B
$2.08M 0.08%
+51,931
New +$2.15M
CYTK icon
207
Cytokinetics
CYTK
$10.6B
$2.04M 0.07%
62,676
-42,913
-41% -$1.59M
OKUR
208
OnKure Therapeutics
OKUR
$160M
$2.01M 0.07%
+30,607
New +$2.47M
ABEO icon
209
Abeona Therapeutics
ABEO
$355M
$2.01M 0.07%
+498,044
New +$1.74M
DIA icon
210
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45B
$1.97M 0.07%
+5,721
New +$1.93M
GAP
211
CALL
The Gap Inc
GAP
$7.3B
$1.95M 0.07%
218,900
-351,100
-62% -$3.13M
XENE icon
212
Xenon Pharmaceuticals
XENE
$6.1B
$1.85M 0.07%
+48,041
New +$1.91M
XOP icon
213
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$1.82M 0.07%
14,161
+9,692
+217% +$1.21M
AVDL
214
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$1.78M 0.06%
+108,000
New +$1.4M
ZIMV
215
DELISTED
ZimVie
ZIMV
$1.76M 0.06%
156,899
-295,445
-65% -$2.87M
CROX icon
216
Crocs
CROX
$6.63B
$1.75M 0.06%
+15,556
New +$1.85M
RENT
217
Rent the Runway
RENT
$124M
$1.71M 0.06%
43,113
+33,926
+369% +$1.67M
LSPD icon
218
PUT
Lightspeed Commerce
LSPD
$1.44B
$1.69M 0.06%
99,700
+84,700
+565% +$1.22M
PRTK
219
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.68M 0.06%
758,431
-157,070
-17% -$326K
GT icon
220
Goodyear
GT
$2.09B
$1.65M 0.06%
+120,694
New +$1.51M
NEXT icon
221
CALL
NextDecade
NEXT
$1.68B
$1.64M 0.06%
200,000
-550,100
-73% -$3.38M
WNS
222
DELISTED
WNS Holdings
WNS
$1.6M 0.06%
21,750
+12,750
+142% +$1.02M
AKAM icon
223
Akamai
AKAM
$15.6B
$1.6M 0.06%
+17,783
New +$1.52M
CCL icon
224
Carnival Corporation Ltd
CCL
$38.1B
$1.56M 0.06%
82,648
+39,745
+93% +$465K
IJR icon
225
iShares Core S&P Small-Cap ETF
IJR
$109B
$1.55M 0.06%
+15,591
New +$1.48M
7 8
9
10 11

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2023 Portfolio in Review

As of Q2 2023, J. Goldman & Co held 537 positions worth $2.75B, up 11% from $2.47B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

J. Goldman & Co deployed $98.4M of net new capital in Q2 2023, opening 191 new positions and adding to 80 existing holdings. Its largest new stake was Splunk Inc: 342,083 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Uber, an estimated $43.5M trimmed.

  • J. Goldman & Co's largest Q2 2023 buy was Splunk Inc: 342,083 shares worth $36.3M.
  • J. Goldman & Co added most to iShares Russell 2000 ETF in Q2 2023, an estimated $44.3M increase.
  • J. Goldman & Co's biggest Q2 2023 reduction was Uber, cutting an estimated $43.5M.
  • J. Goldman & Co fully exited Meta Platforms (Facebook) in Q2 2023, selling an estimated $61.8M.
  • J. Goldman & Co's ten largest holdings make up 25% of its $2.75B portfolio in Q2 2023.
  • J. Goldman & Co opened 191 new positions and closed 170 in Q2 2023.
  • J. Goldman & Co's portfolio value rose 11% quarter-over-quarter to $2.75B.

Based on J. Goldman & Co's 13F filing for Q2 2023, filed 14 Aug 2023.